Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Moderate-to-severe plaque psoriasis, described by PASI ≥10%, can be associated with higher cardiovascular risk according to seven risk algorithms: Results of a 10-year single-center retrospective study and clinical management of psoriatic patients with cardiovascular risk.

Literature DB >> 33098612

Moderate-to-severe plaque psoriasis, described by PASI ≥10%, can be associated with higher cardiovascular risk according to seven risk algorithms: Results of a 10-year single-center retrospective study and clinical management of psoriatic patients with cardiovascular risk.

Claudio Conforti¹, Damiano Currado², Luca Navarini², Chiara Retrosi¹, Roberta Giuffrida³, Enrico Zelin¹, Antonella Afeltra², Nicola di Meo¹, Caterina Dianzani⁴, Iris Zalaudek¹.

Abstract

Entities: Disease Species

Mesh：

Year: 2020 PMID： 33098612 DOI： 10.1111/dth.14451

Source DB: PubMed Journal: Dermatol Ther ISSN： 1396-0296 Impact factor: 2.851

Keyword Cloud
Cited

× No keyword cloud information.

4 in total

1. Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis.

Authors: Luca Navarini; Damiano Currado; Annalisa Marino; Stefano Di Donato; Alice Biaggi; Francesco Caso; Luisa Costa; Marco Tasso; Piero Ruscitti; Viktoriya Pavlych; Onorina Berardicurti; Antonio Ciancio; Ilenia Pantano; Federica Camarda; Maria Sole Chimenti; Arianna D'Antonio; Francesco Ursini; Addolorata Corrado; Francesco Paolo Cantatore; Roberto Perricone; Giuliana Guggino; Francesco Ciccia; Paola Cipriani; Raffaele Scarpa; Antonella Afeltra; Roberto Giacomelli
Journal: Sci Rep Date: 2022-05-07 Impact factor: 4.996

Moderate-to-severe plaque psoriasis, described by PASI ≥10%, can be associated with higher cardiovascular risk according to seven risk algorithms: Results of a 10-year single-center retrospective study and clinical management of psoriatic patients with cardiovascular risk.

1. Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis.

2. Psoriasis Severity and Cardiometabolic Risk Factors in a Representative US National Study.

Review 3. Cardiovascular Safety of Biologics Targeting Interleukin (IL)-12 and/or IL-23: What Does the Evidence Say?

4. The risk of psoriasis in patients with uveitis: A nationwide population-based cohort study.